About: Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: $5.87 (-2.17%)
AVR NASDAQ Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp. Common Stock share price
AVR price activity
Last Price
$5.870
Change (24hr)
-0.13 USD (2.17%)
Volume
901.77K
Volume (4w avg)
-
Open
$6.00
Day Range
$5.85 - $6.08
Previous Close
$6.00
Last Trade
23 Oct, 8:17 pm GMT+0
Delayed
23 Oct, 8:17 pm GMT+0
AVR price performance
Delayed
23 Oct, 8:17 pm GMT+0
AVR Market Signals